Side-by-side comparison of AI visibility scores, market position, and capabilities
Meta's standalone VR headset line with Quest 3 ($499) and Quest 3S ($299) mixed reality; $40B+ invested in Reality Labs competing with PlayStation VR2 and Apple Vision Pro for the XR platform.
Meta Quest is Meta Platforms' (NASDAQ: META) standalone virtual reality headset line — the Quest 3 (launched October 2023, $499 for 128GB) and Quest 3S (launched October 2024, $299) offering mixed reality (color passthrough that blends virtual content with the real world), inside-out tracking (no external sensors), and access to the Meta Quest Store with 500+ apps spanning gaming, fitness, social VR, and enterprise applications. Meta has invested over $40 billion in Reality Labs (its metaverse/VR/AR division) since 2019, generating approximately $2 billion in annual Quest hardware and software revenue while posting multi-billion-dollar annual operating losses in the division.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.